Schistosomiasis Misleading Gastric Cancer Treatment

  • Marcus Fernando Kodama Pertille RamosEmail author
  • Vinicius Campos Duarte
  • Marina Alessandra Pereira
  • Tiago Biachi de Castria
  • Claudia Kliemann Schmerling
  • Bruno Zilberstein
  • Ulysses Ribeiro-Júnior
  • Ivan Cecconello
Case Report


Gastric cancer (GC) is the 5th most common cancer and the 3rd leading cause of cancer-related death worldwide [1]. Gastrectomy with D2 lymphadenectomy is considered the standard surgical treatment for locally advanced GC [2]. Recently, neoadjuvant chemotherapy (CMT) has been indicated for patients with T3/T4 tumors and/or lymph node involvement (N+) [3]. Schistosomiasis is a parasitic disease caused by different Schistosoma species and is considered one of the most socio-economically devastating parasitic diseases worldwide [4]. It is endemic in some tropical areas but as the flow of immigrants and travelers is increasing across the globe, it is important to be aware of it when considering differential diagnosis of gastrointestinal diseases [5, 6].

Case Presentation

A 62-year-old female patient was referred to our Hospital with symptom of epigastric pain for 6 months. She had no comorbidity, previous abdominal surgeries, and history of alcohol consumption. The body mass...


Authors’ Contributions

Marcus Fernando Kodama Pertille Ramos: Attending surgeon of the case, responsible for the report design and draft of the manuscript.

Vinicius Campos Duarte: Gastrointestinal surgery resident took part in the surgical procedure and gathered the clinical information for the report.

Marina Alessandra Pereira, Claudia Kliemann Schmerling: pathological review.

Tiago Biachi de Castria: medical oncologist, report design.

Ulysses Ribeiro-Júnior, Bruno Zilberstein, Ivan Cecconello: critical analysis and review of the manuscript.

Compliance with Ethical Standards

This report was approved by the Hospital Ethics Committee (NP 1439/18) and informed consent was obtained.

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Cunningham D, Allum WH, Stenning SP, Thompson JN, van de Velde C, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.CrossRefGoogle Scholar
  2. 2.
    Isaji S, Mizuno S, Windsor JA, Bassi C, Fernández-del Castillo C, Hackert T, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology. 2018;18:2–11.CrossRefGoogle Scholar
  3. 3.
    Ryan ET, Aquino SL, Kradin RL. Case records of the Massachusetts General Hospital. Case 29-2007. A 51-year-old man with gastric cancer and lung nodules. N Engl J Med. 2007;357:1239–46.CrossRefGoogle Scholar
  4. 4.
    Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.CrossRefGoogle Scholar
  5. 5.
    Tustumi F, Bernardo WM, Dias AR, et al. Detection value of free cancer cells in peritoneal washing in gastric cancer: a systematic review and meta-analysis. Clinics (Sao Paulo). 2016;71:733–45.CrossRefGoogle Scholar
  6. 6.
    Gaye AM, Doh K, Thiam I, Bentefouet L, Woto-Gaye G. Schistosomiasis and cancer: a fortuitous association or relationships cause and effect. Bull Cancer. 2016;103:806–7.CrossRefGoogle Scholar
  7. 7.
    Silva-Moraes V, Shollenberger LM, Siqueira LMV, et al. Diagnosis of Schistosoma mansoni infections: what are the choices in Brazilian low-endemic areas? Mem Inst Oswaldo Cruz. 2019;114:e180478.CrossRefGoogle Scholar
  8. 8.
    Atlanta CR. Clifton road Atlanta: center for disease control and prevention, 2018.Google Scholar
  9. 9.
    Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100:1–441.Google Scholar
  10. 10.
    Coelho FF, Perini MV, Kruger JA, Fonseca GM, Araújo RL, Makdissi FF, et al. Management of variceal hemorrhage: current concepts. Arq Bras Cir Dig. 2014;27:138–44.CrossRefGoogle Scholar
  11. 11.
    Ramos M, Pereira MA, Yagi OK, et al. Surgical treatment of gastric cancer: a 10-year experience in a high-volume university hospital. Clinics (Sao Paulo). 2018;73:e543s.Google Scholar
  12. 12.
    Darre T, Djiwa T, Dare S, et al. Difficult causality relationship between colorectal cancer and schistosomiasis. Pathol Oncol Res. 2019.Google Scholar
  13. 13.
    Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRefGoogle Scholar
  14. 14.
    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRefGoogle Scholar
  15. 15.
    Istre GR, Fontaine RE, Tarr J, Hopkins RS. Acute schistosomiasis among Americans rafting the Omo River, Ethiopia. JAMA. 1984;251:508–10.CrossRefGoogle Scholar
  16. 16.
    Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.CrossRefGoogle Scholar
  17. 17.
    Gryseels B. Schistosomiasis. Infect Dis Clin North Am. 2012;26:383–97.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Cancer Institute, Hospital das Clínicas HCFMUSP, Faculdade de MedicinaUniversidade de São PauloSão PauloBrazil

Personalised recommendations